EUVIMEDEUVIMED entdecken
Open Access

Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function

Lauren F Sestito iD, Kim H T To, Matthew T Cribb iD, Paul A Archer iD, Susan N Thomas iD, J Brandon Dixon iD

Science Advances · 2023

DOI: 10.1126/sciadv.abq0435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Lauren F Sestito und 5 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter School of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA. Hauptthemen laut MEDLINE: Lymphatic Vessels. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysfunction of collecting lymphatic vessel pumping is associated with an array of pathologies. S-(−)-Bay K8644 (BayK), a small-molecule agonist of L-type calcium channels, improves vessel contractility ex vivo but has been left unexplored in vivo because of poor lymphatic access and risk of deleterious off-target effects. When formulated within lymph-draining nanoparticles (NPs), BayK acutely improved lymphatic vessel function, effects not seen from treatment with BayK in its free form. By preventing rapid drug access to the circulation, NP formulation also reduced BayK’s dose-limiting side effects. When applied to a mouse model of lymphedema, treatment with BayK formulated in lymph-draining NPs, but not free BayK, improved pumping pressure generated by intact lymphatic vessels and tissue remodeling associated with the pathology. This work reveals the utility of a lymph-targeting NP platform to pharmacologically enhance lymphatic pumping in vivo and highlights a promising approach to treating lymphatic dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic VesselsMiceAnimals3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterDisease Models, AnimalPressure

Substanzen

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester

Autor:innen und Institutionen

  • Wallace H. Coulter School of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.
  • Department of Mechanical Engineering and Bioengineering, Valparaiso University, 1900 Chapel Dr, Valparaiso, IN 46383, USA.
  • George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
  • Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.
  • Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.

ORCID-Profile: Lauren F Sestito, Matthew T Cribb, Paul A Archer, Susan N Thomas, J Brandon Dixon

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NIBIB NIH HHS

Zitieren

APA

Sestito, L. F., To, K. H. T., Cribb, M. T., Archer, P. A., Thomas, S. N., & Dixon, J. B. (2023). Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function. Science Advances. https://doi.org/10.1126/sciadv.abq0435

Vancouver

Sestito LF, To KHT, Cribb MT, Archer PA, Thomas SN, Dixon JB. Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function. Science Advances. 2023. doi:10.1126/sciadv.abq0435

BibTeX
@article{Sestito2023,
  author = {Sestito, Lauren F and To, Kim H T and Cribb, Matthew T and Archer, Paul A and Thomas, Susan N and Dixon, J Brandon},
  title = {Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.abq0435}
}
Kostenlos starten →